SUBJECTS : Psychopharmacology | Mental Health | Psychiatry | Mental Disorder
LATEST MANUSCRIPTS IN Therapeutic Advances in Psychopharmacology
- Antonio Augusto Schmitt Junior, Lucas Primo de Carvalho Alves, Barbara Larissa Padilha, Neusa Sica da Rocha. Serum cytokine variations among inpatients with major depression, bipolar disorder, and schizophrenia healthy controls: a prospective 'true-to-life' study. Therapeutic advances in psychopharmacology. 2023, 13: 20451253221135463
Cited : 3Read More - David Taylor, Koichiro Watanabe. Tardive dyskinesia: understanding current challenges in diagnosis and treatment. Therapeutic advances in psychopharmacology. 2023, 13: 20451253221144347Cited : 2Read More
- Christy Huff, A J Reid Finlayson, D E Foster, Peter R Martin. Enduring neurological sequelae of benzodiazepine use: an Internet survey. Therapeutic advances in psychopharmacology. 2023, 13: 20451253221145561Cited : 7Read More
- Fabrice Jollant, Romain Colle, Thi Mai Loan Nguyen, Emmanuelle Corruble, Alain M Gardier, Martin Walter, Mocrane Abbar, Gerd Wagner. Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231151327Cited : 24Read More
- Ingrid Lieber, Michael Ott, Robert Lundqvist, Mats Eliasson, Ursula Werneke. Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231151514Cited : 4Read More
- Si Bo Liu, Shan Liu, Kai Gao, Guo Zhi Wu, Guo Zu, Jin Jie Liu. Olanzapine for the treatment of ICU delirium: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231152113Cited : 3Read More
- Anya Ragnhildstveit, Jeremy Roscoe, Lisa C Bass, Christopher L Averill, Chadi G Abdallah, Lynnette A Averill. The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231154125Cited : 8Read More
- Alexander T Gallo, Stephen Addis, Vlad Martyn, Hishani Ramanathan, Grace K Wilkerson, Kellie S Bennett, Sean D Hood, Hans Stampfer, Gary K Hulse. The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistance. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231156400Cited : 0Read More
- John M Kane, Jose M Rubio. The place of long-acting injectable antipsychotics in the treatment of schizophrenia. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231157219Cited : 3Read More
- Mishal Qubad, Robert A Bittner. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231158152Cited : 9Read More
- Francesco Bartoli, Daniele Cavaleri, Christian Nasti, Dario Palpella, Pierluca Guzzi, Ilaria Riboldi, Cristina Crocamo, Sofia Pappa, Giuseppe Carrà. Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231163682Cited : 10Read More
- Femin Prasad, Riddhita De, Vittal Korann, Araba F Chintoh, Gary Remington, Bjørn H Ebdrup, Dan Siskind, Filip Krag Knop, Tina Vilsbøll, Anders Fink-Jensen, Margaret K Hahn, Sri Mahavir Agarwal. Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231165169Cited : 14Read More
- Louisa Gannon, John Reynolds, Martin Mahon, Fiona Gaughran, John Lally. High-dose olanzapine in treatment-resistant schizophrenia: a systematic review. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231168788Cited : 2Read More
- Vivian W L Tsang, Brendan Tao, Shannon Dames, Zach Walsh, Pam Kryskow. Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231171512Cited : 4Read More
- Jim van Os, Peter C Groot. Outcomes of hyperbolic tapering of antidepressants. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231171518Cited : 5Read More
